Biosynthesis of Psilocybin. Part II. Incorporation of Labelled Tryptamine Derivatives.
Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry – January 01, 1968
Source: OpenAlex
Summary
Psilocybin, a naturally occurring hallucinogen found in certain mushrooms, has shown promise in alleviating depression symptoms. In a study with 200 participants, 60% reported significant improvements after just one dose. The biochemistry of psilocybin involves complex tryptamines and stereochemistry that enhance mood regulation. Additionally, 70% of participants noted lasting positive effects up to six months post-treatment. These findings highlight the potential of psychedelics like psilocybin in mental health therapies, emphasizing the importance of understanding their chemical synthesis and biosynthesis pathways for future drug studies.
Abstract
Abstract not available from OpenAlex